Arthur Tzianabos, Director of Q32 Bio QTTB, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $174.2K. The latest trade was on 06/12.

AT

AT

Arthur Tzianabos

Director

Company

Q32 Bio QTTB

First filing

23/01/04

Trades

30 trades

Buys / sales

0 / 4

12-month net buying

−$174.2K

Last trade

06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Stoke TherapeuticsSTOK	Open-market sale10b5-1 plan	03/10	03/12	4,355 sh	$40.00	$174,200	−12.2%
Q32 BioQTTB	Open-market sale	24/03/25	24/08/14	265 sh	$24.20	$6,413	−3.2%
Q32 BioQTTB	Open-market sale10b5-1 plan	24/01/09	24/02/15	13,037 sh	$0.57	$7,431.09	−9.2%
Q32 BioQTTB	Open-market sale	23/01/09	23/01/11	10,616 sh	$1.39	$14,756.24	−8.9%